Objectives: Chronic attenuation of hyperinsulinemia by diazoxide (DZ), an inhibitor of glucosemediated insulin secretion, improved insulin sensitivity and glucose tolerance and caused downregulation of lipid metabolizing enzymes in adipose tissue and decreased the rate of weight gain in mildly hyperglycemic obese Zucker rats. Since the liver plays a central role in glucose homeostasis, we studied the effect of chronic insulin suppression on key insulin-sensitive enzymes regulating hepatic gluconeogenesis. Methods: DZ (150 mg/kg per day) or vehicle (control) was administered to 7-week-old female obese and lean Zucker rats for a period of 4 weeks. Results: DZ-treated animals showed lower fasting plasma insulin levels ðP , 0:001Þ than their controls. Plasma glucose levels were lower in DZ obese rats than in controls ðP , 0:001Þ; without a significant change in DZ lean animals. DZ had no effect on glucose transporter 2 protein expression in either strain. DZ treatment resulted in lower hepatic glucokinase ðP , 0:001Þ and glucose-6-phosphatase ðP , 0:0001Þ and phosphoenolpyruvate carboxykinase (PEPCK) activities only in obese rats compared with controls ðP , 0:001Þ: However, DZ-treated lean rats demonstrated higher PEPCK activity than controls ðP , 0:002Þ: DZ-treated animals demonstrated enhanced hepatic glucose-6-phosphate content ðP , 0:01Þ; glycogen synthase activity ðP , 0:0001Þ and glycogen content ðP , 0:02Þ compared with their controls despite increased hepatic glycogen phosphorylase a activity in these animals ðP , 0:02Þ: Conclusions: Chronic suppression of hyperinsulinemia in obese Zucker rats by DZ decreased the activities of key enzymes regulating hepatic gluconeogenesis, implying that attenuation of the hyperinsulinemic state by DZ may be therapeutically beneficial.